Literature DB >> 7739626

Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.

R C Griggs1, R Tawil, M McDermott, J Forrester, D Figlewicz, B Weiffenbach.   

Abstract

Facioscapulohumeral dystrophy (FSHD) is an autosomal-dominant disorder with a characteristic and distinctive distribution of weakness but a high degree of variation in the age of onset and rate of progression. Monozygotic twins provide the opportunity to assess the relative importance of genetic as opposed to nongenetic influences on the course of disease. We have studied three sets of monozygotic twins with FSHD and compared the similarity of their degree of involvement using quantitative studies of individual muscle function. Similar quantitative studies of 59 other subjects with FSHD served as a reference population for contrast with the twin studies. One set of twins was discordant for FSHD, presumably as a reflection of a postzygotic mutation in the affected twin. The other two sets were concordant and both had evidence of autosomal dominantly inherited gene rearrangements. Both sets were similarly affected in terms of age of onset, overall degree of disability, and quantitative tests of muscle, but there were major differences in the symmetry of involvement of specific muscles. Cerebral dominance was not related to asymmetries of involvement. These data suggest age of onset and severity are determined by the gene lesion in FSHD. Other factors may influence the frequently encountered asymmetries in FSHD.

Entities:  

Mesh:

Year:  1995        PMID: 7739626

Source DB:  PubMed          Journal:  Muscle Nerve Suppl


  9 in total

Review 1.  Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease.

Authors:  Charis L Himeda; Takako I Jones; Peter L Jones
Journal:  Antioxid Redox Signal       Date:  2014-12-04       Impact factor: 8.401

Review 2.  Facioscapulohumeral Muscular Dystrophy.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Continuum (Minneap Minn)       Date:  2016-12

3.  Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.

Authors:  Yvonne D Krom; Julie Dumonceaux; Kamel Mamchaoui; Bianca den Hamer; Virginie Mariot; Elisa Negroni; Linda N Geng; Nicolas Martin; Rabi Tawil; Stephen J Tapscott; Baziel G M van Engelen; Vincent Mouly; Gillian S Butler-Browne; Silvère M van der Maarel
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

Review 4.  New perspectives on the development of muscle contractures following central motor lesions.

Authors:  J Pingel; E M Bartels; J B Nielsen
Journal:  J Physiol       Date:  2016-12-07       Impact factor: 5.182

5.  Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.

Authors:  Isabella Scionti; Francesca Greco; Giulia Ricci; Monica Govi; Patricia Arashiro; Liliana Vercelli; Angela Berardinelli; Corrado Angelini; Giovanni Antonini; Michelangelo Cao; Antonio Di Muzio; Maurizio Moggio; Lucia Morandi; Enzo Ricci; Carmelo Rodolico; Lucia Ruggiero; Lucio Santoro; Gabriele Siciliano; Giuliano Tomelleri; Carlo Pietro Trevisan; Giuliana Galluzzi; Woodring Wright; Mayana Zatz; Rossella Tupler
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

Review 6.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

7.  Epigenetic alterations in muscular disorders.

Authors:  Chiara Lanzuolo
Journal:  Comp Funct Genomics       Date:  2012-06-18

8.  Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.

Authors:  Takako I Jones; Oliver D King; Charis L Himeda; Sachiko Homma; Jennifer C J Chen; Mary Lou Beermann; Chi Yan; Charles P Emerson; Jeffrey B Miller; Kathryn R Wagner; Peter L Jones
Journal:  Clin Epigenetics       Date:  2015-03-29       Impact factor: 6.551

Review 9.  Does DNA Methylation Matter in FSHD?

Authors:  Valentina Salsi; Frédérique Magdinier; Rossella Tupler
Journal:  Genes (Basel)       Date:  2020-02-28       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.